JPRN-UMIN000016980Not yet recruitingPhase 1
Effects of nattokinase on the patients with eosinophilic chronic rhinosinusitis - Effects of nattokinase on the patients with eosinophilic chronic rhinosinusitis
niversity of Fukui0 sites320 target enrollmentStarted: April 1, 2015Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 320
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 15years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1)The patient who is complicated with a nose disease (severe septum deviation, severe allergic rhinitis, nose or paranasal sinus tumor) that make this study difficult. 2)The case that the steroid dosage cannot cancel for the treatment of this disease and other diseases. 3)The case that has allergy for Natto or soybean. 4)Under during the pregnancy or the nursing 5)Patient during medical treatment of immunity 6)The patient who judged that the medical attendant was inappropriate
Investigators
Similar Trials
Recruiting
Phase 2
Oxytocin & benzodiazepines2024-516262-11-00St. Olavs Hospital HF60
Completed
Not Applicable
The effects of oral nattokinase intake on blood fibrinolysis, coagulation and inflammatory profile during exerciseAdultJPRN-UMIN000027685Department of Sports Medicine for Health Promotion, Tokyo Medical University20
Recruiting
Not Applicable
Effect of nitric oxide synthase (NOS) activity on Lenvatinib for unresectable hepatocellular carcinomaJPRN-jRCT1030210283Hidaka Hisashi100
Recruiting
Phase 1
Peripheral arterial disease and its circulating markers that show reflect the causative factorsCTRI/2018/01/011512AIIMS New Delhi150
Recruiting
Not Applicable
Effect of oral neurokinin-1 antagonist, aprepitant for chemotherapy-induced nausea and vomiting in patients with gynecologic cancer receiving carboplatin/paclitaxel chemotherapy.JPRN-UMIN000005317Department of gynecology, Fukuoka University Hospital60
